Dr. Srivatsan Raghavan is a Physician in Medical Oncology at Dana-Farber Cancer Institute and an Assistant Professor of Medicine at Harvard Medical School. He completed his MD/PhD training at Johns Hopkins University, residency in internal medicine at Johns Hopkins Hospital, and fellowship in medical oncology at Dana-Farber/Harvard Cancer Center. He sees patients within the Gastrointestinal Cancer Center at Dana-Farber Cancer Institute and at Brigham and Women's Hospital, and directs a research laboratory focused on new therapies for patients with pancreatic and biliary tract cancers.